Falcigo
Falcigo contains Artesunate, a water-soluble hemisuccinate derivative of artemisinin. It is a highly effective antimalarial agent used for the rapid treatment of severe malaria. It works by generating reactive free radicals that damage and kill the malaria parasite within the host's red blood cells.
Dosage by Body Weight
Typically administered via intravenous (IV) or intramuscular (IM) injection in a hospital setting. The standard WHO recommendation is 2.4 mg/kg for adults and children weighing 20 kg or more, and 3.0 mg/kg for infants and children weighing less than 20 kg. Given at 0, 12, and 24 hours, followed by once daily doses. Patients should switch to a full course of oral artemisinin-based combination therapy (ACT) as soon as they can tolerate oral medication.
- Body Weight
- Below 5 kg
- Dose
- 3.0 mg/kg body weight
- Frequency
- At 0, 12, and 24 hours, then once daily
- Tracking Notes
- Requires critical care monitoring. Must be reconstituted carefully with the provided solvent and diluent.
- Body Weight
- 5-7 kg
- Dose
- 15 mg to 21 mg (3.0 mg/kg)
- Frequency
- At 0, 12, and 24 hours, then once daily
- Tracking Notes
- Administer intravenously over 1-2 minutes or by deep intramuscular injection.
- Body Weight
- 8-10 kg
- Dose
- 24 mg to 30 mg (3.0 mg/kg)
- Frequency
- At 0, 12, and 24 hours, then once daily
- Tracking Notes
- Ensure exact calculation based on the child's actual weight. Follow up with oral ACT when stable.
- Body Weight
- 11-15 kg
- Dose
- 33 mg to 45 mg (3.0 mg/kg)
- Frequency
- At 0, 12, and 24 hours, then once daily
- Tracking Notes
- Monitor for potential side effects such as transient neutropenia or hemolysis.
- Body Weight
- 16-20 kg
- Dose
- 48 mg to 60 mg (3.0 mg/kg)
- Frequency
- At 0, 12, and 24 hours, then once daily
- Tracking Notes
- Patients weighing exactly 20 kg or above should transition to the adult/older child dosage of 2.4 mg/kg.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | 3.0 mg/kg body weight | At 0, 12, and 24 hours, then once daily | Requires critical care monitoring. Must be reconstituted carefully with the provided solvent and diluent. |
| 5-7 kg | 15 mg to 21 mg (3.0 mg/kg) | At 0, 12, and 24 hours, then once daily | Administer intravenously over 1-2 minutes or by deep intramuscular injection. |
| 8-10 kg | 24 mg to 30 mg (3.0 mg/kg) | At 0, 12, and 24 hours, then once daily | Ensure exact calculation based on the child's actual weight. Follow up with oral ACT when stable. |
| 11-15 kg | 33 mg to 45 mg (3.0 mg/kg) | At 0, 12, and 24 hours, then once daily | Monitor for potential side effects such as transient neutropenia or hemolysis. |
| 16-20 kg | 48 mg to 60 mg (3.0 mg/kg) | At 0, 12, and 24 hours, then once daily | Patients weighing exactly 20 kg or above should transition to the adult/older child dosage of 2.4 mg/kg. |
Formulation
Purpose
Treatment of severe malaria, including cerebral malaria, caused by Plasmodium falciparum.
Generic Name
ArtesunateScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.